Coave Therapeutics
Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS.
Saint-Jacques-de-la-Lande, Francecoavetx.com ↗
Total raised
€53M
€53,200,000
Funding rounds
2
Investors
15
distinct backers
Active since
2021-07
latest 2025-01
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood55
base rate 44% for Series A
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood14
base rate 12% (2+ rounds)
- ▲ €30M+ raised
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-01-09 | Series A | €32M | Bpifrance,Fund plus,Invus,Kurma Partners,Novo Holdings,Omnes Capital+3 more | View deal → |
| 2021-07-21 | Series B | €21M | eureKARE,Fund plus,Go Capital,Idinvest,Kurma Partners,Omnes Capital+4 more | View deal → |
Investors
15Related news
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software